How quickly do you think hematologists will adopt the recently approved midostaurin for FLT3+ AML patients - 101341

Spotlight
Video

How quickly do you think hematologists will adopt the recently approved midostaurin for FLT3+ AML patients

obr has 300 videos Subscribe Here

Loading........
Description: Aref Al-Kali, MD of Mayo Clinic discusses the approval of midostaurin for FLT3+ AML patients. This was recorded at the 2017 ASCO Annual Meeting in Chicago, IL.
Shared By : obr
Posted on : 06/19/17
Added : 10 months ago